| Literature DB >> 25391043 |
Kerstin Golker1, Björn C G Karlsson2, Annika M Rosengren3, Ian A Nicholls4.
Abstract
In this report, principal component analysis (PCA) has been used to explore the influence of template complexation in the pre-polymerization phase on template molecularly imprinted polymer (MIP) recognition and polymer morphology. A series of 16 bupivacaine MIPs were studied. The ethylene glycol dimethacrylate (EGDMA)-crosslinked polymers had either methacrylic acid (MAA) or methyl methacrylate (MMA) as the functional monomer, and the stoichiometry between template, functional monomer and crosslinker was varied. The polymers were characterized using radioligand equilibrium binding experiments, gas sorption measurements, swelling studies and data extracted from molecular dynamics (MD) simulations of all-component pre-polymerization mixtures. The molar fraction of the functional monomer in the MAA-polymers contributed to describing both the binding, surface area and pore volume. Interestingly, weak positive correlations between the swelling behavior and the rebinding characteristics of the MAA-MIPs were exposed. Polymers prepared with MMA as a functional monomer and a polymer prepared with only EGDMA were found to share the same characteristics, such as poor rebinding capacities, as well as similar surface area and pore volume, independent of the molar fraction MMA used in synthesis. The use of PCA for interpreting relationships between MD-derived descriptions of events in the pre-polymerization mixture, recognition properties and morphologies of the corresponding polymers illustrates the potential of PCA as a tool for better understanding these complex materials and for their rational design.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25391043 PMCID: PMC4264184 DOI: 10.3390/ijms151120572
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Compositions of the molecularly imprinted polymers prepared with methacrylic acid (MAA) (in mmol) a. MIP, molecularly-imprinted polymer; EGDMA, ethylene glycol dimethacrylate; AIBN, 2,2'-azobis-(2-methylpropionitrile).
| Polymer | Bupivacaine | MAA | EGDMA | AIBN | Toluene | Molar Ratio b |
|---|---|---|---|---|---|---|
| MIP 0 | 1.39 | 0.00 | 77.4 | 2.00 | 219.8 | 1:0:56 |
| MIP 1 | 1.39 | 3.30 | 78.1 | 2.10 | 226.0 | 1:2:56 |
| MIP 2 | 1.39 | 7.23 | 74.5 | 2.03 | 221.5 | 1:5:54 |
| MIP 3 | 1.39 | 12.51 | 77.4 | 2.18 | 236.4 | 1:9:56 |
| MIP 4 | 1.39 | 16.68 | 77.4 | 2.23 | 240.9 | 1:12:56 |
| MIP 5 | 1.39 | 20.1 | 82.3 | 2.40 | 259.4 | 1:14:59 |
| MIP 6 | 1.39 | 22.24 | 77.4 | 2.30 | 246.9 | 1:16:56 |
| MIP 7 | 1.39 | 25.02 | 77.4 | 2.30 | 251.4 | 1:18:56 |
| MIP 8 | 1.39 | 30.90 | 82.6 | 2.55 | 274.0 | 1:22:59 |
| MIP 9 | 1.39 | 64.20 | 76.2 | 2.80 | 298.4 | 1:46:55 |
a Non-imprinted reference polymers were also prepared, though in the absence of bupivacaine. b Bupivacaine:MAA:EGDMA.
Composition of the molecularly imprinted polymers prepared with methyl methacrylate (MMA) (in mmol) a.
| Polymer | Bupivacaine | MMA | EGDMA | AIBN | Toluene | Molar Ratio b |
|---|---|---|---|---|---|---|
| MIP 0 | 1.39 | 0.00 | 77.4 | 2.00 | 219.8 | 1:0:56 |
| MIP 10 | 1.39 | 7.23 | 77.4 | 2.18 | 236.4 | 1:7:56 |
| MIP 11 | 1.39 | 13.14 | 77.4 | 2.23 | 240.9 | 1:9.5:56 |
| MIP 12 | 1.39 | 16.90 | 77.4 | 2.30 | 246.9 | 1:12:56 |
| MIP 13 | 1.39 | 19.72 | 77.4 | 2.30 | 251.4 | 1:14:56 |
| MIP 14 | 1.39 | 30.86 | 77.4 | 2.40 | 269.5 | 1:22:56 |
| MIP 15 | 1.39 | 64.22 | 77.4 | 2.80 | 322.2 | 1:46:56 |
a Non-imprinted reference polymers were also prepared, though in the absence of bupivacaine. b Bupivacaine:MMA:EGDMA.
Figure 2The structures of compounds used in the study and the designations of atoms potentially participating in hydrogen bond interactions: (A) Bupivacaine; (B) MAA; (C) EGDMA; (D) MMA.
Figure 1(A) Loading plot of data from equilibrium rebinding studies, swelling studies, morphology characterization and MD (molecular dynamics) simulations on the methacrylic acid (MMA) and methyl methacrylate (MAA) polymer systems; (B) score plot of data showing grouping with respect to the functional monomer used in the respective polymer system. Blue and green: Polymers 1–9 prepared with MAA; red: Polymers 10–15 prepared with MMA; black: Polymer 0 prepared without the functional monomer. See Table 1 and Table 2 for the composition of the polymers. Molar fraction MAA, MfracMAA; molar fraction MMA, MfracMMA; fraction radioligand bound to MIPs, B/TMIP; fraction radioligand bound to REFs, B/TREF; specific binding, B/TSpec; BET surface area of MIPs, BSAMIP; BET surface area of REFs, BSAREF; Langmuir surface area of MIPs, LSAMIP; Langmuir surface area of REFs, LSAREF; pore volume of MIPs, PVMIP; pore volume of REFs, PVREF; swelling ratio of MIPs, SWMIP; swelling ratio of REFs, SWREF; average hydrogen bond contact between bupivacaine and functional monomer (MAA or MMA), %Bup-funcM; average hydrogen bond contact between bupivacaine and EGDMA, %Bup-EGDMA; bupivacaine self-association, %Bup-Bup; contact between amide proton functionality (HAB) of bupivacaine and carbonyl oxygens (OAD) of either MMA or MAA, %HAB-OAD; contact between amide proton of bupivacaine and carbonyl oxygen (OAF) of EGDMA, %HAB-OAF. See Figure 2 for atom labels.